<DOC>
	<DOCNO>NCT02961348</DOCNO>
	<brief_summary>This study compare early late start treatment Non-vitamin K oral anticoagulation ( NOAC ) adult patient acute ischemic stroke atrial fibrillation ; registry-based randomized clinical trial ( R-RCT ) use The Swedish Stroke Register ( Riksstroke ) . Half patient start NOAC early ( within 4 day stroke onset ) half start late ( 5-10 day stroke onset ) .</brief_summary>
	<brief_title>TIMING Oral Anticoagulant Therapy Acute Ischemic Stroke With Atrial Fibrillation</brief_title>
	<detailed_description>Oral anticoagulation therapy well establish highly recommended prevention recurrent ischemic stroke patient atrial fibrillation , optimal time point start acute ischemic stroke know . The intervention study time treatment onset . The choice NOAC ( i.e . apixaban , dabigatran , edoxaban rivaroxaban ) acute ischemic stroke discretion treat physician . This study use Swedish Stroke Register enrolment , randomization follow-up , additional data linkage mandatory national register . Primary outcome assess 90 day secondary outcome ( include all-cause mortality health economic analysis ) assess 90 day one year index ischemic stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Adult patient ( ≥ 18 year ) acute ischemic stroke atrial fibrillation Eligible willing start ( restart ) NOAC Registered The Swedish Stroke Register Signed informed consent Contraindication NOAC ( e.g . ongoing bleeding , mechanical heart valve prosthesis ) Ongoing therapy NOAC ( without ≥2 day interruption index stroke ) International normalize ratio ( INR ) &gt; 1.7 No second brain imaging ( CT/MRI ) thrombolysis/thrombectomy Previous randomization TIMING study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Oral anticoagulant ( NOAC )</keyword>
</DOC>